The ornithine transcarbamylase deficiency market reached a value of USD 689.1 Million across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the... Read More
Author: marketreport
The IgA nephropathy (IgAN) market reached a value of USD 127.0 Million across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the... Read More
The 7 major hypophosphatasia markets reached a value of US$ 725.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,036.4 Million by 2034, exhibiting a... Read More
The triple-negative breast cancer market reached a value of US$ 490.5 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the... Read More
The 7 major tardive dyskinesia markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting... Read More